Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving patient care through the development and commercialization of innovative medicines that help people with diabetes and obesity.

At Amylin, our mission is to improve the lives of people with diabetes worldwide. We strive to be an engaged leader in the global fight against diabetes, obesity, and other chronic diseases. By providing innovative treatments and pioneering new approaches, we lead the industry as a trusted partner for our customers, providing dependable solutions and effective care.

At Amylin, we strive to be the most respected and reliable therapeutic solutions provider to people with diabetes and obesity. We will achieve this by delivering world-class products and services that exceed customer expectations.

Amylin has earned both the Drug Information Association Innovator Award for excellence in development and commercialization of amylin-based therapeutics, and the American Diabetes Association's Harrington Award for excellence in diabetes research.